Clinical trial
Does Erythropoietin Improve Outcome in Very Preterm Infants?
NCT00413946 · Swiss Neonatal Network, Other · Completed
Key facts
| NCT number | NCT00413946 |
|---|---|
| Title | Does Erythropoietin Improve Outcome in Very Preterm Infants? |
| Official title | Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants |
| Lead sponsor | Swiss Neonatal Network, Other |
| Collaborators | Swiss National Science Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intracranial Hemorrhage, Periventricular Leukomalacia, Cerebral Palsy, Developmental Psychomotor Disorders |
| Intervention type | Drug |
| Interventions | Recombinant human Erythropoietin, saline |
| Enrollment | 420 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Dec 20, 2006 |
| Last update posted | Oct 30, 2018 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: